Cargando…
Resolution of C1q deposition but not of the clinical nephrotic syndrome after immunomodulating therapy in focal sclerosis
Background: The natural evolution of C1q nephropathy (C1qNP) during immunosuppressive treatment is relatively little studied or understood. Case Presentation: A 30 year-old Caucasian female was referred to us for further management of biopsy-proven C1qNP and severe nephrotic syndrome. Serologic work...
Autores principales: | Tibor Fülöp, Tibor, Csongrádi, Éva, Lerant, Anna A., Lewin, Matthew, Lewin, Jack R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Diabetic Nephropathy Prevention
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417671/ https://www.ncbi.nlm.nih.gov/pubmed/25964890 http://dx.doi.org/10.12860/jnp.2015.11 |
Ejemplares similares
-
Acute oxalate nephropathy associated with orlistat
por: Humayun, Youshay, et al.
Publicado: (2016) -
Kidney biopsy for renal tubular acidosis: when tissue diagnosis makes a difference
por: Humayun, Youshay, et al.
Publicado: (2015) -
Association Between NPHS2 p.R229Q and Focal Segmental Glomerular Sclerosis/Steroid-Resistant Nephrotic Syndrome
por: Zhou, Qiongxiu, et al.
Publicado: (2022) -
Diffuse membranoproliferative glomerulonephritis with focal sclerosis and renal amyloidosis in an adult male with autosomal dominant dystrophic epidermolysis bullosa: a case report
por: Soliman, Karim M., et al.
Publicado: (2019) -
Permeability factors in nephrotic syndrome and focal segmental glomerulosclerosis
por: Savin, Virginia J., et al.
Publicado: (2012)